| Business Summary | | Dendrite
International,
Inc.
is
a
global
provider
of
a
comprehensive
range
of
customer
relationship
management
(CRM)
software
products
and
support
services
to
the
pharmaceutical
industry.
The
Company's
CRM
solutions
enable
its
customers
to
effectively
manage
the
activities
of
large
sales
forces
in
complex
selling
environments.
These
solutions
also
permit
pharmaceutical
companies
to
create
a
central
repository
of
information
about
each
of
their
customers,
which
is
integrated
and
analyzed
to
maximize
the
value
derived
from
each
customer.
Dendrite
also
supplies
CRM
solutions
to
manufacturers
of
consumer-packaged
goods
(CPG).
The
Company's
CPG
products
are
targeted
at
manufacturers
whose
sales
representatives
call
on
retail
outlets
and
enable
sales
representatives
to
manage
all
aspects
of
their
call
reporting
obligations,
including
the
collection
of
pricing,
promotions
and
product
placement
information.
In
addition,
its
products
integrate
sales
information
from
a
number
of
data
sources. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Dendrite
International
is
a
worldwide
supplier
of
sales
force
software
products
and
support
services
to
the
pharmaceutical
industry.
For
the
six
months
ended
6/30/01,
revenues
increased
5%
to
$103.8
million.
Net
loss
totaled
$18.1
million
vs.
an
income
of
$13.4
million.
Revenues
reflect
increased
services
revenue
due
to
an
increased
number
of
installed
users.
Loss
reflects
lower
gross
margins
and
$15.8
million
in
restructuring
and
asset
impairment
charges. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| John Bailye, 47 Chairman,
CEO | $554K | $2.6M | Michael Atieh, 47 CFO,
Sr. VP | -- | -- | R. Savage, 52 Exec.
VP and COO | 386K | 2.2M | George Robson, 53 Exec.
VP | 394K | 2.7M | Theresa Winslow, 45 Sr.
VP and Pres, Americas Division | 448K | 1.3M | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|